Medical Equipment

NGS-Based RNA-Sequencing Market 2025–2029: Tracking 25% CAGR Toward $10.26 Billion in Revenue

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the ngs-based rna-sequencing market from 2025–2034 with trusted insights from The Business Research Company

How Will The NGS-Based RNA-Sequencing Market Size Evolve Between Now And 2029?

The ngs-based rna-sequencing market has witnessed significant growth over recent years. Its valuation is set to rise from $3.41 billion in 2024 to $4.2 billion in 2025, progressing at a compound annual growth rate (CAGR) of 23.3%. This historical expansion can be attributed to several factors including genomic research initiatives, the reduction in sequencing costs, advancements in drug discovery and development, the development of personalized medicine, and increasing adoption of ngs technology.

The ngs-based rna-sequencing market is projected for rapid expansion over the coming years. This market is anticipated to reach a valuation of $10.26 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 25.0%. Factors driving this growth during the forecast period encompass clinical diagnostics, global collaborations, ethical and regulatory frameworks, agricultural and environmental research, and green genomics. Key trends identified for the same period involve single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

Which Key Drivers Are Powering Growth In The NGS-Based RNA-Sequencing Market?

The expansion of precision medicine is a key factor propelling the NGS-based RNA sequencing market. This medical approach assists physicians in crafting bespoke treatment strategies and making therapeutic choices informed by a patient’s genetic disease profile. An increase in precision medicine applications is observed, particularly for managing serious illnesses like cancer. NGS-based RNA sequencing facilitates the pinpointing of disease origins, enabling the prescription of targeted precision medicine for effective treatment. As an illustration, a February 2023 report from the US-based nonprofit Personalized Medicine Coalition (PMC) indicated that personalized medicines constituted 35% of novel NME approvals in 2021. Furthermore, with 12 new approvals in 2022, their share has consistently remained at least a quarter of all new drug approvals for the last eight years, a notable rise from less than 10% a decade prior. Consequently, the rising demand for precision medicines is expected to drive a corresponding increase in the need for NGS-based RNA sequencing.

How Is The Global NGS-Based RNA-Sequencing Market Structured By Key Segments?

The ngs-based rna-sequencingmarket covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Future-Focused Trends Are Anticipated In The NGS-Based RNA-Sequencing Market?

Strategic collaborations are identified as a prominent trend within the NGS-based RNA sequencing market. Companies are forging partnerships with NGS-based RNA sequencing enterprises to expand into new regions and pool their respective resources. For example, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), an agency under the U.S. Department of Health and Human Services, established a partnership with various industry and academic organizations. This collaboration is designed to bolster the capacity for prompt responses to public health emergencies and to develop a novel diagnostic capability capable of identifying all recognized and emerging respiratory RNA viruses in one comprehensive test.

Which Companies Hold A Competitive Edge In The NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Region Is Expected To Lead The NGS-Based RNA-Sequencing Market In The Next Few Years?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Browse Through More Reports Similar to the Global NGS-Based RNA-Sequencing Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795